• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 型和 III 型干扰素的延迟诱导介导了鼻腔上皮细胞对 SARS-CoV-2 的易感性。

Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.

机构信息

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Nat Commun. 2021 Dec 7;12(1):7092. doi: 10.1038/s41467-021-27318-0.

DOI:10.1038/s41467-021-27318-0
PMID:34876592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8651658/
Abstract

The nasal epithelium is a plausible entry point for SARS-CoV-2, a site of pathogenesis and transmission, and may initiate the host response to SARS-CoV-2. Antiviral interferon (IFN) responses are critical to outcome of SARS-CoV-2. Yet little is known about the interaction between SARS-CoV-2 and innate immunity in this tissue. Here we apply single-cell RNA sequencing and proteomics to a primary cell model of human nasal epithelium differentiated at air-liquid interface. SARS-CoV-2 demonstrates widespread tropism for nasal epithelial cell types. The host response is dominated by type I and III IFNs and interferon-stimulated gene products. This response is notably delayed in onset relative to viral gene expression and compared to other respiratory viruses. Nevertheless, once established, the paracrine IFN response begins to impact on SARS-CoV-2 replication. When provided prior to infection, recombinant IFNβ or IFNλ1 induces an efficient antiviral state that potently restricts SARS-CoV-2 viral replication, preserving epithelial barrier integrity. These data imply that the IFN-I/III response to SARS-CoV-2 initiates in the nasal airway and suggest nasal delivery of recombinant IFNs to be a potential chemoprophylactic strategy.

摘要

鼻腔上皮是 SARS-CoV-2 的一个合理进入点,是发病和传播的部位,可能引发宿主对 SARS-CoV-2 的反应。抗病毒干扰素(IFN)反应对于 SARS-CoV-2 的结果至关重要。然而,人们对该组织中 SARS-CoV-2 与先天免疫之间的相互作用知之甚少。在这里,我们应用单细胞 RNA 测序和蛋白质组学技术,对在气液界面分化的人鼻腔上皮原代细胞模型进行研究。SARS-CoV-2 对鼻腔上皮细胞类型表现出广泛的嗜性。宿主反应以 I 型和 III 型 IFN 以及干扰素刺激基因产物为主。与其他呼吸道病毒相比,这种反应在病毒基因表达方面明显延迟。然而,一旦建立,旁分泌 IFN 反应开始对 SARS-CoV-2 的复制产生影响。在感染前给予重组 IFNβ 或 IFNλ1 会诱导有效的抗病毒状态,强烈限制 SARS-CoV-2 病毒的复制,保持上皮屏障的完整性。这些数据表明,SARS-CoV-2 引发的 IFN-I/III 反应始于鼻腔气道,并表明鼻腔内给予重组 IFN 可能是一种潜在的化学预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/e91ae54f1e50/41467_2021_27318_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/7b94a071d707/41467_2021_27318_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/e65c403278ad/41467_2021_27318_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/999e5b5ed026/41467_2021_27318_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/3c8ad88d793c/41467_2021_27318_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/1b4b3c80f7b9/41467_2021_27318_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/b207d259db0a/41467_2021_27318_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/e91ae54f1e50/41467_2021_27318_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/7b94a071d707/41467_2021_27318_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/e65c403278ad/41467_2021_27318_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/999e5b5ed026/41467_2021_27318_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/3c8ad88d793c/41467_2021_27318_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/1b4b3c80f7b9/41467_2021_27318_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/b207d259db0a/41467_2021_27318_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec1a/8651658/e91ae54f1e50/41467_2021_27318_Fig7_HTML.jpg

相似文献

1
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.I 型和 III 型干扰素的延迟诱导介导了鼻腔上皮细胞对 SARS-CoV-2 的易感性。
Nat Commun. 2021 Dec 7;12(1):7092. doi: 10.1038/s41467-021-27318-0.
2
Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice.单细胞转录组学揭示了小鼠鼻上皮中抗病毒干扰素反应的区室化。
J Virol. 2025 Mar 18;99(3):e0141324. doi: 10.1128/jvi.01413-24. Epub 2025 Feb 4.
3
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
4
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.Ⅰ型和Ⅲ型干扰素限制 SARS-CoV-2 感染人呼吸道上皮细胞。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00985-20.
5
SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.SARS-CoV-2 分离株在人免疫细胞中的复制能力受损,但在肺上皮细胞中的复制能力和诱导先天免疫能力存在差异。
Microbiol Spectr. 2021 Sep 3;9(1):e0077421. doi: 10.1128/Spectrum.00774-21. Epub 2021 Aug 11.
6
Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.鼻上皮细胞中的干扰素信号转导可区分致死性和普通感冒冠状病毒,并介导病毒清除。
Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2402540121. doi: 10.1073/pnas.2402540121. Epub 2024 May 17.
7
Age-Related Expression of IFN-λ1 IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals.年龄相关性 IFN-λ1、IFN-I 和 β 防御素在 SARS-CoV-2 感染个体鼻咽部的表达。
Front Immunol. 2021 Nov 10;12:750279. doi: 10.3389/fimmu.2021.750279. eCollection 2021.
8
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.高温可抑制呼吸道上皮细胞中的 SARS-CoV-2 复制,而与 IFN 介导的固有免疫防御无关。
PLoS Biol. 2021 Dec 21;19(12):e3001065. doi: 10.1371/journal.pbio.3001065. eCollection 2021 Dec.
9
Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.III型干扰素在新冠患者中的保护作用:从I型和III型干扰素的差异特性中汲取的经验教训
Viral Immunol. 2021 Jun;34(5):307-320. doi: 10.1089/vim.2020.0076. Epub 2020 Nov 4.
10
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.人肠上皮细胞中 SARS-CoV-2 对 III 型干扰素的敏感性增加。
J Virol. 2022 Apr 13;96(7):e0170521. doi: 10.1128/jvi.01705-21. Epub 2022 Mar 9.

引用本文的文献

1
Distinct circulating autoantibodies are associated with COVID-19 hospitalization and SARS-CoV-2 neutralization activity.不同的循环自身抗体与COVID-19住院治疗及SARS-CoV-2中和活性相关。
Npj Viruses. 2025 Sep 2;3(1):64. doi: 10.1038/s44298-025-00149-2.
2
Airway Epithelial SARS-CoV-2 Infectious and Repair Responses: Relationships to Age, Sex, and Post-COVID Pulmonary Syndromes.气道上皮细胞对严重急性呼吸综合征冠状病毒2的感染与修复反应:与年龄、性别及新冠后肺部综合征的关系
bioRxiv. 2025 Jul 17:2025.07.17.663733. doi: 10.1101/2025.07.17.663733.
3
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.

本文引用的文献

1
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.上呼吸道预先激活的抗病毒先天免疫可控制儿童早期 SARS-CoV-2 感染。
Nat Biotechnol. 2022 Mar;40(3):319-324. doi: 10.1038/s41587-021-01037-9. Epub 2021 Aug 18.
2
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.早期针对 SARS-CoV-2 的鼻腔 I 型 IFN 免疫被针对 I 型 IFN 的自身抗体患者削弱。
J Exp Med. 2021 Oct 4;218(10). doi: 10.1084/jem.20211211. Epub 2021 Aug 6.
3
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
4
Identification of virus-rich intermediate cells as crucial players in SARS-CoV-2 infection and differentiation dynamics of human airway epithelium.鉴定富含病毒的中间细胞是新冠病毒感染及人气道上皮细胞分化动力学中的关键因素。
Front Microbiol. 2024 Dec 13;15:1507852. doi: 10.3389/fmicb.2024.1507852. eCollection 2024.
5
Human coronaviruses: activation and antagonism of innate immune responses.人类冠状病毒:先天免疫反应的激活与拮抗
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0001623. doi: 10.1128/mmbr.00016-23. Epub 2024 Dec 19.
6
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19.气道中一过性抗干扰素自身抗体与 COVID-19 的康复有关。
Sci Transl Med. 2024 Nov 6;16(772):eadq1789. doi: 10.1126/scitranslmed.adq1789.
7
Regional specialization within the mammalian respiratory immune system.哺乳动物呼吸系统免疫的区域专业化。
Trends Immunol. 2024 Nov;45(11):871-891. doi: 10.1016/j.it.2024.09.011. Epub 2024 Oct 21.
8
IFN Lambda Deficiency Contributes to Severe COVID-19 Outcomes.IFN Lambda 缺陷导致严重 COVID-19 结局。
Int J Mol Sci. 2024 Sep 30;25(19):10530. doi: 10.3390/ijms251910530.
9
A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models.基础活跃的 cGAS-STING 通路限制了 SARS-CoV-2 在部分 ACE2 阳性气道细胞模型中的复制。
Nat Commun. 2024 Sep 27;15(1):8394. doi: 10.1038/s41467-024-52803-7.
10
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry.SARS-CoV-2 奥密克戎亚变种逐渐适应宿主细胞进入机制改变的人类细胞。
mSphere. 2024 Sep 25;9(9):e0033824. doi: 10.1128/msphere.00338-24. Epub 2024 Aug 27.
严重 COVID-19 中 SARS-CoV-2 感染局部固有免疫力受损。
Cell. 2021 Sep 2;184(18):4713-4733.e22. doi: 10.1016/j.cell.2021.07.023. Epub 2021 Jul 23.
4
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach.宿主对 SARS-CoV-2 感染的代谢重编程:系统生物学方法。
Microb Pathog. 2021 Sep;158:105114. doi: 10.1016/j.micpath.2021.105114. Epub 2021 Jul 30.
5
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.IFITM 蛋白促进 SARS-CoV-2 感染,是体外病毒抑制的靶点。
Nat Commun. 2021 Jul 28;12(1):4584. doi: 10.1038/s41467-021-24817-y.
6
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.SARS-CoV-2 感染诱导纤毛细胞去分化,并损害黏液纤毛清除功能。
Nat Commun. 2021 Jul 16;12(1):4354. doi: 10.1038/s41467-021-24521-x.
7
The RNA sensor MDA5 detects SARS-CoV-2 infection.RNA 传感器 MDA5 可检测 SARS-CoV-2 感染。
Sci Rep. 2021 Jul 1;11(1):13638. doi: 10.1038/s41598-021-92940-3.
8
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.动态先天免疫反应决定了对 SARS-CoV-2 感染的易感性和早期复制动力学。
J Exp Med. 2021 Aug 2;218(8). doi: 10.1084/jem.20210583. Epub 2021 Jun 15.
9
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.SARS-CoV-2 非结构蛋白 1 通过导致关键宿主信号因子耗竭来抑制干扰素反应。
J Virol. 2021 Jun 10;95(13):e0026621. doi: 10.1128/JVI.00266-21.
10
Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.SARS-CoV-2 NSP14 蛋白介导的翻译抑制和固有免疫逃避。
Proc Natl Acad Sci U S A. 2021 Jun 15;118(24). doi: 10.1073/pnas.2101161118.